Table 2 Univariate analysis.
 | Statistics | OR (95%CI) | P-value |
---|---|---|---|
Female | 56 (16.3%) | 0.62 (-0.16, 1.39) | 0.119 |
Age, years | 57.97 ± 12.11 | 0.01 (-0.02, 0.03) | 0.620 |
Hypertension, n (%) | 178 (53.78%) | -0.41 (-0.99, 0.17) | 0.164 |
Diabetes mellitus, n (%) | 91 (27.49%) | -0.12 (-0.77, 0.53) | 0.709 |
Hypertriglyceridemia, n (%) | 91 (27.49%) | -0.35 (-1.00, 0.30) | 0.290 |
Smoking, n (%) | 220 (66.47%) | -0.05 (-0.66, 0.56) | 0.871 |
OMI, n (%) | 9 (2.72%) | -0.25 (-2.03, 1.53) | 0.784 |
CRF, n (%) | 7 (2.11%) | 0.37 (-1.64, 2.38) | 0.720 |
Stroke, n (%) | 22 (6.65%) | 0.40 (-0.76, 1.56) | 0.500 |
CHF, n (%) | 4 (1.21%) | 0.15 (-2.50, 2.80) | 0.913 |
History of PCI, n (%) | 12 (3.63%) | -0.28 (-1.83, 1.27) | 0.723 |
WBC,109/L | 9.9 ± 3.4 | 0.2 (0.1, 0.3) | < 0.001 |
PLT,109/L | 234.080 ± 66.157 | -0.004 (-0.008, 0.001) | 0.092 |
HGB, g/L | 145.377 ± 18.326 | -0.004 (-0.020, 0.012) | 0.637 |
Hs-CRP, mg/L | 11.00 ± 35.99 | 0.01 (0.00, 0.02) | 0.007 |
K+, mmol/L | 3.98 ± 0.37 | -0.43 (-1.20, 0.35) | 0.281 |
BG, mmol/L | 8.68 ± 4.35 | 0.14 (0.07, 0.20) | < 0.001 |
cTnI, ng/mL | 1.91 ± 4.83 | 0.06 (-0.00, 0.12) | 0.056 |
ALB, g/L | Â | Â | Â |
LDL-C, mmol/L | 3.22 ± 2.81 | -0.01 (-0.11, 0.10) | 0.900 |
HDL-C, mmol/L | 1.09 ± 0.64 | 0.04 (-0.42, 0.49) | 0.888 |
LEVE, % | 57.73 ± 9.02 | -0.04 (-0.08, -0.01) | 0.016 |
Criminal Vessels | |||
 LM, n (%) | 6 (1.7%) | Rf | Rf |
 LAD, n (%) | 189 (54.8%) | -2.1 (-4.3, 0.1) | 0.061 |
 LCX, n (%) | 42 (12.2%) | -2.2 (-4.6, 0.1) | 0.060 |
 RCA, n (%) | 108 (31.3%) | -2.2 (-4.4, 0.1) | 0.058 |
 IVUS, n (%) | 220 (63.95%) | -1.33 (-1.91, -0.74) | < 0.001 |
 IABP, n (%) | 18 (5.22%) | 2.93 (1.67, 4.19) | < 0.001 |